SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006479
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:10
Documents
4
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220616xdef14a.htm DEF 14A 1004706
2 GRAPHIC tmb-20220616xdef14a015.jpg GRAPHIC 172674
3 GRAPHIC tmb-20220616xdef14a001.jpg GRAPHIC 7956
4 GRAPHIC tmb-20220616xdef14a016.jpg GRAPHIC 131887
  Complete submission text file 0001558370-22-006479.txt   1436840
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 22875188
SIC: 2834 Pharmaceutical Preparations